Preoperative Physical Activity Before Radical Cystectomy and the Impact on Morbidity
PRACTICE
Prospective Randomized Interventional Study to Investigate the Impact of Preoperative Physical Activity on Perioperative Morbidity Following Radical Cystectomy
1 other identifier
interventional
146
1 country
1
Brief Summary
Bladder cancer (BC) is the 6th most common tumor in Europe, with over 540,000 new cases globally each year. While 75% of cases are non-muscle-invasive and treated bladder-preservingly, muscle-invasive, non-metastatic BC requires radical cystectomy (RC), often with neoadjuvant chemotherapy. RC has one of the highest complication rates in urology, and rehabilitation focuses on mitigating functional impairments, restoring physical and mental capacity, and enabling a swift return to daily life. The ERAS (Enhanced Recovery After Surgery) protocol has shown benefits in reducing hospital stays without increasing complications in RC. Prehabilitation studies in cancer patients have demonstrated improvements in strength and fitness, though without significant reductions in complications or mortality. This prospective randomized study, conducted over three years at the University of Munich, will evaluate the effect of preoperative physical activity on perioperative morbidity (primary endpoint). Secondary endpoints include quality of life, hospital stay, mortality, and postoperative physical activity. The intervention group will target 8,000-10,000 daily steps for four weeks preoperatively, monitored via pedometers. Follow-ups will assess physical activity and quality of life at specific intervals pre- and post-surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 29, 2024
CompletedFirst Submitted
Initial submission to the registry
January 15, 2025
CompletedFirst Posted
Study publicly available on registry
February 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 29, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 29, 2027
April 27, 2026
April 1, 2026
2 years
January 15, 2025
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Perioperative Complications
Complications that occur during the postoperative hospital stay
From surgery to 90 days postoperatively
Secondary Outcomes (5)
Physical Fitness Gripstrength
From the day before the surgery as well as up to 12 months after the surgery
HRQOL EORTC-QLQC30
postoperatively, 3 months and 12 months
Patients in need for analgesia
From the day before the surgery up to the discharge from the hospital up to 12 months
6 Minute Walking Test
During the hospitalisation period until 12 months postoperatively
Patients in need of laxatives
From the day before the surgery up to the discharge from the Hospital up to 12 months
Study Arms (2)
Physical Activity
EXPERIMENTALThe intervention group will engage in increased physical activity, aiming for a daily step count of at least 8,000, with a target of 10,000 steps, over a four-week preoperative period. Weekly supervised phone consultations will be conducted to provide guidance and support.
Controll
NO INTERVENTIONThe control group will track their daily physical activity without being required to meet a specific step target. Weekly phone consultations will still be conducted to monitor and support the participants.
Interventions
The intervention group will engage in increased physical activity, aiming for a daily step count of at least 8,000, with a target of 10,000 steps, over a four-week preoperative period. Weekly supervised phone consultations will be conducted to provide guidance and support.
Eligibility Criteria
You may qualify if:
- Urothelial cell cancer of the bladder
- Treatment with radical cystectomy
You may not qualify if:
- Need for walking aid
- Depression
- cardiovascular, neuromuscular or orthopaedic deficites / disorders
- Time to surgery \< 3 Weeks
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Urology, LMU Hospital
Munich, Bavaria, 81377, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 15, 2025
First Posted
February 3, 2025
Study Start
November 29, 2024
Primary Completion (Estimated)
November 29, 2026
Study Completion (Estimated)
November 29, 2027
Last Updated
April 27, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Ethical and legal obligations